Sign in
4

Changes in Ownership

Bionano Genomics, Inc. Filed Acc 0001209191-21-036254

Chief Financial Officer acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Stewart Christopher P. · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-05-26 Exercise or conversion : show line 1 in the form +25,000 $0.56 $14,000 33,000 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-05-26 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −25,000 200,000 D
Loading xslF345X03/doc4.xml…